Continous Hemoglobin Monitoring For Ongoing Blood Loss During Cancer Surgeries Without Needle Prick
Not Applicable
Completed
- Conditions
- Health Condition 1: null- patients undergoing major oncological surgeries involving major blood loss
- Registration Number
- CTRI/2015/04/005685
- Lead Sponsor
- Rajiv Gandhi Cancer Institute
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 50
Inclusion Criteria
ASA Grade I, II, III patient undergoing major elective oncosurgeries with expected blood loss more than 20% of blood volume
Exclusion Criteria
- Patient with known Hemoglobinopathies, arrhythmias, severe hypotension.
- Peripheral Vascular disease like Raynaudâ??s disease.
- Any skin abnormalities affecting the digits.
- Patient on antipsychotic drugs and patient having high total bilirubin levels.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method